Toyota Tsusho, IIJ, NEC, and NTT Com Sign Contract with Uzbektelecom for Telecommunications Infrastructure Development Project

TOKYO - Friday, 27. January 2023

- Contributing to DX efforts by advancing Uzbekistan's information and telecommunications infrastructure -

(BUSINESS WIRE) -- Toyota Tsusho Corporation ("Toyota Tsusho"), Internet Initiative Japan Inc. ("IIJ"), NEC Corporation ("NEC"), and NTT Communications Corporation ("NTT Com") announced today the conclusion of a contract with Uzbektelecom, a state-owned telecommunications operator in Uzbekistan, for a telecommunications infrastructure development project ("the Project") to provide data center and telecommunications infrastructure for an advanced data communication system ("the System").

Installation of the System is scheduled to begin in 2023 and the sequential launch of operations is expected to significantly improve the communications environment of Uzbekistan.

1. Background

In response to the rapidly growing data communication demand driven by the digitalization of various industries, Uzbekistan is expanding its telecommunications infrastructure aimed at issues such as improving communications quality and closing the digital divide between urban and rural areas. In accordance with this background, the government of Uzbekistan has made the decision to accelerate digital transformation (DX) and introduce the latest information technologies for its digitalization strategy, Digital Uzbekistan 2030.

2. Overview

For the Project, launched under Digital Uzbekistan 2030, the four companies will provide telecommunications equipment and services required for Uzbektelecom’s data centers in three major cities (Tashkent, Bukhara, and Kokand), expansion of the telecommunications transport and data networks, as well as the international data communication network. This is expected to significantly increase the speed, capacity, and quality of the telecommunications infrastructure and to contribute to propelling DX in Uzbekistan, thereby facilitating the country's transition to a digital economy in the future.

The Project is funded by the Japan Bank for International Cooperation (JBIC), Nippon Export and Investment Insurance (NEXI), and the MUFG Bank, Ltd.

3. Outlook

Through the Project, the four companies will contribute to the realization of a more convenient and comfortable society, as well as the sustainable development of industries in Uzbekistan and other countries in Central Asia.

[Roles of Participating Companies]

Toyota Tsusho

As the prime contractor for the Project, Toyota Tsusho will serve as the overall coordinator and ensure the smooth progress of the Project.

IIJ

In the data storage and data processing center (data center) construction projects, IIJ will contribute to the development of sustainable digital infrastructure in Uzbekistan by providing its energy efficient, high-quality, and highly efficient containerized IT modules “co-IZmo/I”, building the cloud platform, and providing training for Uzbektelecom's data center operational staff.

NEC

In the Uzbektelecom telecommunications transport network and data network expansion project, NEC will contribute to the operation of the national telecommunications infrastructure by providing optical wavelength multiplexing communications equipment and training for Uzbektelecom's operational staff, leveraging its many years of experience in supporting Uzbekistan's telecommunications infrastructure.

NTT Com

In the international data communication network expansion project, NTT Com will contribute to the realization of DX in Uzbekistan through the expansion of the country's international data communication network by providing equipment for the large-scale communication network and education for Uzbektelecom's operational staff.

[Overview of Toyota Tsusho]

Company name

Toyota Tsusho Corporation

Location

Nagoya City, Aichi Prefecture

Established

July 1, 1948

Capital

64.936 billion yen

Representative

President & CEO Ichiro Kashitani

Business description

Domestic and international trade of goods, export and import of goods, construction undertaking, insurance agents, among others

Website

https://www.toyota-tsusho.com/english/

[Overview of IIJ]

Company name

Internet Initiative Japan Inc.

Location

Chiyoda-ku, Tokyo

Established

December 3, 1992

Capital

23.023 billion yen

Representative

President, co-CEO, and COO Eijiro Katsu

Business description

Provision of Internet connectivity and WAN service, network-related services, network systems construction, operation and maintenance, development and sales of telecommunication equipment

Website

https://www.iij.ad.jp/en/

[Overview of NEC]

Company name

NEC Corporation

Location

Minato-ku, Tokyo

Established

July 17, 1899

Capital

427.8 billion yen

Representative

President and CEO (Representative Director) Takayuki Morita

Business description

Provision of ICT solutions in the areas of public solutions business, public infrastructure business, enterprise business, network services business, and global business

Website

https://www.nec.com/

[Overview of NTT Com]

Company name

NTT Communications Corporation

Location

Chiyoda-ku, Tokyo

Established

1999

Capital

230.9 billion yen

Representative

President & CEO (Representative Member of the Board of the Company) Toru Maruoka

Business description

Long-distance telecommunications in Japan, international telecommunications, solutions business, ICT services and solutions, and related businesses

Website

https://www.ntt.com/en/index.html

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005488/en/

Permalink

https://www.aetoswire.com/en/news/2701202330089

Contacts

[For Press Inquiries Regarding This Release]

Toyota Tsusho Corporation

Corporate Communications Department Tokyo Corporate Communications Group

Tel: +81-3-4306-8200

Internet Initiative Japan Inc.

Corporate Communications Department

Tel: +81-3-5205-6310

E-mail: press@iij.ad.jp

NEC Corporation

Corporate Communications Department

Tel: +81-3-3798-6511

E-mail: press@news.jp.nec.com

NTT Communications Corporation

Public Relations Office, Corporate Strategy Planning Department

Tel: +81-3-6700-4010

[For Customer Inquiries Regarding This Release]

NEC Corporation

Service Provider Solutions Division

E-mail: contact@spsl.jp.nec.com

LG TO DEMONSTRATE ITS LATEST HEALTHCARE INNOVATIONS AT ARAB HEALTH 2023

 As part of its ongoing commitment to pioneering innovation, LG Electronics (LG) will showcase its advanced portfolio of medical imaging technologies at Arab Health 2023, the largest healthcare exhibition in the Middle East. The company will unveil its new medical monitors and upgraded digital X-ray detectors that will be launched in the MEA region in the coming months.

Keeping in mind the sustained demand for healthcare innovations triggered by the prolonged impact of the pandemic, LG continues to expand its product offerings in the medical field, advancing its imaging and surgical visualization technologies based on feedback from medical professionals and patients, and adapting its medical display solutions to the demands of the healthcare environment.

“We are consistently growing our product range and expanding our presence in MEA, recruiting more staff, partnering with new medical distributors along with regional offices of multinational radiology and endoscopy companies. We understand how improved diagnostic accuracy and treatment can make a positive impact on healthcare outcomes, and we strive to provide healthcare professionals with the advanced technologies they need to deliver the best possible patient care,” said Moh’d AlFar, Senior Business Development Manager of LG Electronics Medical Devices in MEA region.

At Arab Health, LG will present its new Diagnostic Monitor (model 32HQ713D) designed to provide improved image quality for diagnostic review. With a large 32-inch 8MP IPS-Black display combined with enhanced brightness and IPS-black panel providing 100% sRGB, the new monitor enables clinicians to easily distinguish even delicate details. Featuring a Multi-resolution mode, LG’s Diagnostic Monitor provides compatibility with all modalities, allowing users to adjust the monitor’s resolution to optimize to the connected device. Additionally, the new monitor is equipped with productivity and comfort features and sensors that ensure more intuitive operation and efficient workflow.

Also on display is an updated version of LG’s Digital X-ray Detector in a new 10-inch size (model 10/14/17HQ701G). Designed to improve diagnostic accuracy, the new detector guarantees high resolution and clear image quality without image distortion. It also increases productivity with fast-processing and improved images transmission, ensuring rapid image availability. With a built-in Hot Swap battery that allows the detector to maintain power for longer, LG’s new Digital X-ray Detector ensures stable and durable performance. In addition, it features an improved design that makes the detector not only exceptionally strong, but also lightweight and portable, making it more convenient to operate.

When it comes to surgical solutions, LG will demonstrate its new Mini-LED Surgical Monitor (model 27HQ710S) that meets all the requirements of the operating room. With a LED 27-inch 4K display with 1,000,000:1 contrast ratio and sRGB over 139%, the new monitor enables detailed observation and ensures accurate colour reproduction with the perfect black. The display also offers an increased peak brightness of 2,000 cd/m2, delivering even more accurate imagery for precise surgery. In addition to this model, LG will also reveal its new 55-inch Surgical Monitor. To learn more about this monitor, please visit LG Electronics Business Solutions booth at the exhibition and see the monitor in a real operation theater set up.

LG will also introduce its LG Calibration Studio (LCS) for calibration at the exhibition, a platform that offers calibration capabilities to all LG medical monitors ensuring highest compatibility, accuracy and standards compliance.

In addition to medical devices, LG will also showcase its latest technologically advanced information displays, such as UHD Hospital TVs designed to meet the specific needs of hospitals, One:Quick Flex and One:Quick Works series for effective business collaboration, LED All-in-One Smart Series for visual communication with superior image quality, as well as Createboard for true interactivity.

Explore LG’s innovative medical solutions at the LG booth at Arab Health 2023 from January 30th to February 2nd, located at Dubai World Trade Centre (DTWC), Sheikh Saeed Hall 2, stand number S2.F30.

For more information, please visit: https://www.lg.com/global/business/virtual-showroom/medical-display

 

# # #

About LG Electronics Business Solutions Company

The LG Business Solutions Company is a trusted partner offering innovative products and solutions for diverse industries worldwide. With a portfolio of unique offerings ranging from industry-leading OLED and LED signage to high efficiency solar solutions, LG is a respected name among customers around the world. LG’s IT solutions include business monitors, laptops, projectors, cloud devices, medical displays and commercial robots, all designed to maximize work efficiency and return strong value to customers. For more on LG’s Business Solutions, visit www.LG.com/b2b.

Permalink

https://www.aetoswire.com/en/news/2601202330045

Contacts

LG-One 

Nora Nassar

Email: nora.nassar@lg-one.com

CEO Change at dSPACE: Dr. Carsten Hoff Succeeds Martin Goetzeler

 PADERBORN, Germany - Thursday, 26. January 2023




(BUSINESS WIRE) -- On April 17, 2023, Dr. Carsten Hoff (49) will become the new CEO of the dSPACE group succeeding Martin Goetzeler (60), who is leaving his post at his own request and for personal reasons. To ensure a smooth handover, Martin Goetzeler will continue to be available to the new CEO in an advisory capacity after April 17, 2023.

Dr. Carsten Hoff is a highly experienced manager, who is ideally suited to the tasks ahead at dSPACE. He comes from a research and development-centric background with a degree in electrical engineering and a doctorate in computer science. He has international management experience and is familiar with dSPACE and the company's products.

Dr. Carsten Hoff is currently Managing Director of CLAAS E-Systems. Prior to that, he worked in various management positions at the automotive supplier HELLA. He will use his extensive experience from previous positions to provide strategic impetus for dSPACE and to continue to drive forward the new topics of software-based simulation and validation.

"I am very pleased to be joining the dSPACE company. I am very impressed by the company's development and dSPACE's role in the automotive industry. The values that the family-owned company dSPACE stands for convinced me,” stated Dr. Carsten Hoff.

"Dr. Carsten Hoff, an internationally experienced and technically skilled manager who is very familiar with the current challenges in our target markets is taking the helm – I wish him a good start in the company and with our customers," said Dr. Herbert Hanselmann, founder and shareholder of dSPACE.

"Under Martin Goetzeler's successful leadership, dSPACE has sustainably strengthened its market position by setting a decisive course in terms of consistent portfolio expansion, globalization, and future-oriented structures. By continually expanding future investments and the team, he has succeeded in continuing the great growth rate at a high level of sales in challenging years," said Dr. Herbert Hanselmann, adding, "We regret but respect Martin Goetzeler's decision. I would like to expressly thank him for his important contribution, his extraordinary commitment, and the close cooperation based on trust."

"It has been an exciting five years. The excellent and close cooperation with the entire dSPACE team, our customers and partners, and the shareholder family was the key to success and motivation at all times. I would like to thank everyone very much for this," said Martin Goetzeler. "After a fulfilling professional career, I would like to devote more time to my personal and family tasks and interests in the future. I wish my successor and all dSPACE employees the necessary skills, much success, and all the best for the future," said Goetzeler.

Martin Goetzeler has led the dSPACE company since March 1, 2018. Portfolio expansions in virtual and real simulation and validation to cover market and customer requirements in a timely manner, especially in automated and autonomous driving and in the software-defined vehicle were important milestones during this time. In addition to the great importance of software-in-the-loop simulation in this process, technologies such as AI and cloud are now also being used in the products. At the same time, he systematically built up structures and processes to sustainably secure the strong global growth.

About dSPACE

dSPACE is a leading provider of simulation and validation solutions worldwide for developing networked, autonomous, and electrically powered vehicles. The company's range of end-to-end solutions are used particularly by automotive manufacturers and their suppliers to test the software and hardware components in their new vehicles long before a new model is allowed on the road. Not only is dSPACE a sought-after partner in vehicle development, engineers also rely on our know-how at dSPACE when it comes to aerospace and industrial automation. Our portfolio ranges from end-to-end solutions for simulation and validation to engineering and consulting services as well as training and support. With approximately 2,200 employees worldwide, dSPACE is headquartered in Paderborn, Germany, has three project centers in Germany, and serves customers through regional dSPACE companies in the USA, the UK, France, Japan, China, Croatia, and South Korea.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005072/en/


Permalink
https://aetoswire.com/en/news/2601202330052
Contacts
dSPACE GmbH
Bernd Schäfers-Maiwald
Vice President Corporate Communications
Tel: +49 5251 1638-714
E-Mail: bschaefers-maiwald@dspace.de

Saudi reaffirms commitment to bridging global divides, driving energy transition, inclusive economic growth at WEF23

 Riyadh, Saudi Arabia - Wednesday, 25. January 2023

Saudi Arabia reiterated its commitment to build bridges across geopolitical and economic divides at the World Economic Forum (WEF) 2023 Annual Meeting in Davos, Switzerland last week.

 

His Highness Prince Faisal bin Farhan Al Saud, Minister of Foreign Affairs, led the Saudi delegation of nine ministers and high-level officials, and told the world that geopolitical stability is key to energy security, and the Kingdom has “become the meeting place between East and West”.

 

During the week, Saudi Arabia hosted a dialogue titled ‘Toward a Resilient Urban Resource Nexus’, with key international public and private sector stakeholders from regional and global organizations discussing the sustainability of future cities.

 

His Highness Prince Faisal, Her Royal Highness Princess Reema, His Excellency Alswaha, His Excellency Alkhorayef and His Excellency Alibrahim participated in a multilateral meeting with WEF leadership, Klaus Schwab, Founder and Executive Chairman, and Børge Brende, President, to explore areas of mutual interest.

 

During the meeting, His Excellency Alswaha, Chairman of the Board of King Abdulaziz City for Science and Technology (KACST) and Chairman of the Board of The Research, Development and Innovation Authority (RDIA) and Brende, signed a Letter of Intent (LoI) to establish a new accelerator program to help ignite innovation in Saudi Arabia.

 

The Saudi delegates highlighted the Kingdom's role as a Pioneering Partner in the Forum's Global Collaboration Village, which will leverage the Metaverse to serve the global community.

 

Separately, the Ministry of Investment, in coordination with the Ministry of Energy and the Ministry of Industry and Mineral Resources, organized a high-level dialogue for executives from the energy, petrochemicals and mining sectors to discuss the impact of the energy transition, the role of petrochemical industries and investments needed to achieve net zero by 2060.

 

Meanwhile, Saudi Arabia’s Ministry of Economy and Planning – in collaboration with the WEF open innovation platform UpLink – launched a challenge to crowdsource transformative solutions to secure local food in countries impacted by low rainfall, drought and desertification.

 

The Food Ecosystems and Arid Climates Challenge is a global call for food entrepreneurs, start-ups, social ventures, and SMEs to submit solutions that incorporate low or high technologies or ancestral responses.

 

Also during the week, Saudi Arabia – represented by the Ministry of Economy and Planning – joined the WEF Jobs Consortium, a coalition of CEOs, IOs, ministers and other leaders with a common aim to promote a better future of work for all by enabling job creation and job transitions.

 

The Saudi Arabian delegation also engaged in a wide range of bilateral meetings, dialogues with global leaders, ministers and CEOs and – for the first time – public panel sessions as part of WEF’s Open Forum. These included discussions with high-level public and private sector representatives from several countries and were an opportunity to share the Kingdom’s vision while exploring potential partnerships and areas of collaboration.

Permalink

https://www.aetoswire.com/en/news/saudi-reaffirms-commitment-to-bridging-global-divides,-driving-energy-transition,-inclusive-economic-growth-at-wef23

Contacts

Wauod Alquaied

walquaied@mep.gov.sa

Carbios Strengthens Executive Committee in Pivotal Year for Industrial and Commercial Development

CLERMONT-FERRAND, France - Thursday, 26. January 2023

• Appointment of Martine BRISSET as General Manager Biodegradation Division, Senior Vice President of Carbios Group, and Executive Committee Member
• Appointment of Delphine DENOIZÉ, Innovation Programs Funding, Regulation and LCA Director, as Executive Committee Member

(BUSINESS WIRE)--Regulatory News:

Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies for reinventing the life cycle of plastics and textiles, has strengthened its leadership team with the appointment of Martine BRISSET as Senior Vice President from 1 January 2023. Martine will manage the Biodegradation Division and supervise the Human Resources, Legal, Regulatory, Project Management, Quality Health and Safety departments. Martine BRISSET joins the Group's Executive Committee, as does Delphine DENOIZÉ, who remains Innovation Programs Funding, Regulation and LCA Director with an expanding team.

"Over the past six months, our teams have grown significantly in order to achieve our ambitious targets, and I am very pleased to appoint Martine and Delphine to the Executive Committee," commented Emmanuel LADENT, Chief Executive Officer of Carbios. "Their proven track records, notably within the Carbios Group, strengthen the top management’s expertise and reinforces the diversity of skills needed to succeed in this pivotal year for Carbios’ industrialization and commercialization.”

Martine BRISSET, Senior Vice President of Carbios : “After having supervised the production of thousands of tons of plastic destined for the packaging sector, I am now focused on reducing plastic pollution with our biodegradation and biorecycling solutions. I'm very excited to take on this awesome and exciting challenge, one that makes sense for future generations and for industry."

Martine BRISSET has over 30 years of General Management experience in major international groups within the plastic and paper packaging industry, most notably at Amcor, Huhtamaki, Linpac and Klockner Pentaplast. Since 2021, she has held the position of General Manager of Carbiolice in order to integrate this high-potential subsidiary dedicated to biodegradation within the Carbios Group. In her new position as Senior Vice President of Carbios, her main mission will be to successfully deploy the biodegradation technology, facilitate the international expansion of Carbios' activities, organise the recruitment and training of the Group's employees. With numerous recruitments planned throughout the company in 2023, building Carbios’ attractivity will be a strategic topic.

Delphine DENOIZÉ, Innovation Programs Funding, Regulation and LCA Director : "What drives me is the satisfaction of seeing a project through, from concept to reality. At Carbios, all our projects have a positive impact on the environment, and it’s rising to this challenge that makes me passionate about my work. By becoming a member of the Executive Committee, I will support these projects even more enthusiastically, in terms of their structuring and funding, but also in terms of their regulatory compliance and environmental performance.”

After several years working in innovation within the agricultural industry, it was during her time at Céréales Vallées cluster that Delphine DENOIZÉ discovered and assisted in the creation of Carbios. She joined the company in 2016 and was one of its first twenty employees. Initially in charge of Innovation Funding and Regulation, then Project Management for PET biorecycling, she now oversees all the Group’s projects. Her responsibilities include French and European public funding for innovation, regulatory compliance of processes and products around the world, and assessment of their environmental impact through specific tools such as Life Cycle Assessment.

Executive Committee Members of Carbios Group:

    Emmanuel LADENT, Chief Executive Officer
    Lionel ARRAS, Industrial Development Director
    Mathieu BERTHOUD, Sourcing and Public Affairs Director
    Pascal BRICOUT, Chief Strategy and Financial Officer
    Martine BRISSET, General Manager Biodegradation Division and Senior Vice President of Carbios Group
    Delphine DENOIZÉ, Innovation Programs Funding, Regulation and LCA Director
    Stéphane FERREIRA, Chief Business Officer
    Lise LUCCHESI, Intellectual Property Director
    Prof. Alain MARTY, Chief Scientific Officer

Visit Carbios’ website for biographies of each individual member: https://www.carbios.com/en/governance/

About Carbios

Established in 2011 by Truffle Capital, Carbios is a green biotech company, developing biological and innovative processes. Through its unique approach of combining enzymes and plastics, Carbios aims to address new consumer expectations and the challenges of a broad ecological transition by taking up a major challenge of our time: plastic and textile pollution. Carbios deconstructs any type of PET (the dominant polymer in bottles, trays, textiles made of polyester) into its basic components which can then be reused to produce new PET plastics with equivalent quality to virgin ones. This PET innovation, the first of its kind in the world, was recently recognized in a scientific paper published in front cover of the prestigious journal Nature. Carbios successfully started up its demonstration plant in Clermont-Ferrand in 2021. It has now taken another key step towards the industrialization of its process with the construction of a first-of-a-kind unit in partnership with Indorama Ventures.

In 2017, Carbios and L’Oréal co-founded a consortium to contribute to the industrialization of its proprietary recycling technology. Committed to developing innovative solutions for sustainable development, Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe joined this consortium in April 2019. In 2022, Carbios signed an agreement with On, Patagonia, PUMA, and Salomon, to develop solutions promoting the recyclability and circularity of their products.

The Company has also developed an enzymatic biodegradation technology for PLA-based (a bio sourced polymer) single-use plastics. This technology can create a new generation of plastics that are 100% compostable at ambient temperatures, even in domestic conditions, integrating enzymes at the heart of the plastic product.

For more information, please visit carbios.com / Twitter: Carbios / LinkedIn: Carbios / Instagram: insidecarbios

Carbios (ISIN FR0011648716/ALCRB) is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.

Translation is for information purposes only.
In case of discrepancy between the French and the English version of this press release, the French version shall prevail

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005432/en/

Permalink
https://www.aetoswire.com/en/news/2601202330072

Contacts

CARBIOS
Melissa Flauraud
Press Relations
melissa.flauraud@carbios.com
Benjamin Audebert
Investor Relations
contact@carbios.com
+33 (0)4 73 86 51 76

Press Relations (Europe)
Iconic
Marie-Virginie Klein
mvk@iconic-conseil.com
+33 (0)1 44 14 99 96

Press Relations (U.S.)
Rooney Partners
Kate L. Barrette
kbarrette@rooneyco.com
+1 212 223 0561

Press Relations (DACH)
MC Services
Anne Hennecke
carbios@mc-services.eu
+49 (0)211 529 252 22

Galderma Announces the Launch of FACE by Galderma™ – a Game-Changing Augmented Reality Solution Helping Healthcare Professionals Grow Their Activity and Improve Patient Satisfaction

 ZUG, Switzerland - Thursday, 26. January 2023




FACE by Galderma™ is a cutting-edge aesthetic visualization application that simulates the results of injectable treatments in real time, using digital facial assessment
The application provides advanced wrinkle detection as well as the possible results of 19 injectable treatments, which are displayed as dynamic “before and after” images
The solution offers a holistic approach to individualized care, empowering patients to pursue their treatment plan with confidence
In a global pilot study, 80% of respondents said the application helped them to understand their treatment options. Meanwhile, 85% stated that they would recommend the application, and 91% said they plan to return to their practitioner to continue their treatment plan1
(BUSINESS WIRE) -- Galderma has announced the launch of FACE by Galderma™, an innovative augmented reality application. The ground-breaking solution enables aesthetic practitioners and patients to visualize treatment results at the planning stage. The technology will be presented to the aesthetic scientific community at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris on January 26-28.

FACE by Galderma™ gives patients a real-time, realistic “before and after” view of possible results from an individualized treatment plan. This helps address concerns about end results while also enabling better understanding of a holistic treatment approach, ultimately leading to greater patient satisfaction1.

 

 

“We developed this game-changing solution to support aesthetic practitioners and give patients a visual representation of what they can expect from the procedures included in their treatment plan. For example, the real-time injectable results feature simulates how a treatment might augment a patient’s lips, cheeks or chin. FACE by Galderma™ offers patients a realistic visual of their results before treatment even begins, supporting them to establish treatment objectives and priorities alongside their practitioner. It gives them the freedom to make their aesthetic goals a reality.”

 

GERRY MUHLE

HEAD OF GLOBAL BUSINESS UNIT, AESTHETICS
GALDERMA

 

 

FACE by Galderma™ allows for an immersive, fully interactive consultation process and enables the aesthetic practitioner to evaluate the entire face in real time. The assessment is based on Galderma’s Five Facet Assessment that considers skin quality, facial shape, facial symmetry, facial proportions, and contour, as well as animation and emotional expression. Following the assessment, priority areas can be identified, and an individualized treatment plan can be created. By taking a full-face approach, FACE by Galderma™ ensures that the practitioner provides a holistic treatment plan that meets the patient’s needs. The technology behind FACE by Galderma™ was developed in partnership with Crisalix, the worldwide leading reference in 3D, virtual reality and augmented reality aesthetic simulation.

 

 

“FACE by Galderma™ ushers in a level of innovation previously unseen in the aesthetics industry. This unique technology has the potential to transform how consultations are conducted and is ideal for showcasing the possibilities of Galderma’s impressive portfolio of injectables.”

 

JAIME GARCIA
CHIEF EXECUTIVE OFFICER
CRISALIX

 

 

The results of a recent global pilot study of FACE by Galderma™ were extremely promising. Of the respondents, 80% said the application helped them to understand their treatment options, while 73% agreed that it made them contemplate a procedure they had not previously considered. Meanwhile, 61% stated that they plan to show their “before and after” images to friends. Overall, 85% said they would recommend the application, and 91% said they plan to return to their practitioner to continue their individualized treatment plan1.

 

 

“Patients come to my practice for a consultation because they are interested in an aesthetic injectable procedure, often have questions and are apprehensive about how the procedure will turn out and whether it will look natural and address their wrinkles. The advanced technology available via the new FACE by Galderma tool provides my patients with a simulation of their outcome in advance of the procedure, which should help alleviate their concerns and build trust.”

 

ALEKSANDRA BIELAWIEC

NURSE PRACTITIONER AND AESTHETIC MASTER INJECTOR

REGENCY MEDICAL SPA & HAIR CLINIC IN BARRINGTON, ILLINOIS

 

 

FACE by Galderma™ features 19 potential injectable results using products from the Galderma portfolio (depending on local indications), enabling patients to see simulated visuals in real time. Treatment options include:

Neuromodulators, such as DYSPORT®, AZZALURE® (EU) and ALLUZIENCE® (the first ready-to-use liquid botulinum toxin type A, approved in June 2021 for use in Europe (excluding Greece, Lithuania, Estonia, Latvia and Hungary)).
Biostimulators, including SCULPTRA®
Products from the hyaluronic acid filler range, RESTYLANE® and RESTYLANE® SKINBOOSTERS
The tool also facilitates patient management, acting as a “patient passport.” It enables clinics to store all patient records in one place, including the treatment plan, “before and after” video and images, and appointment schedules. Patients can also access their FACE by Galderma™ account and view their individual patient profile from home.

FACE by Galderma™ will be available in the United States and Brazil in the first half of 2023, with a global roll out across Latin America, Europe, Middle East, Canada and Asia throughout 2023.

About Galderma
Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com

About Crisalix
Crisalix is the online international simulation & imaging standard for Before & After aesthetic, reconstructive or skin treatments, supporting healthcare professionals and educating patients on their options. Thanks to our disruptive online imaging solution, powered by state-of-the-art Artificial Intelligence and Computer Vision techniques, our exclusive platform is used by patients, leading medical aesthetic brands and the most recognized medical providers throughout the full patient journey. With unbeaten key improvements on the main medical data and related business metrics, we focus to enhance the beauty journey of people around the world, day after day, with game changing 3D, 4D, Virtual Reality and Augmented Reality visualization.

About Alluzience® (liquid botulinum toxin type A)
Alluzience (liquid botulinum toxin type A) is the first ready-to-use BoNT-A liquid neuromodulator formulation to be introduced in Europe. Alluzience should only be administered by a physician with appropriate qualifications and expertise in this treatment using the required equipment.2 Dosing and treatment intervals depend on assessment of the individual patient’s response.2 The treatment interval should be no more frequent than every three months.2 For more information, please see the Summary of Product Characteristics.2

Alluzience is a product under license from Ipsen. Alluzience is a registered trademark of Ipsen. Galderma has an exclusive license from Ipsen to develop, promote and distribute Alluzience in the approved indication in several European countries.

About Dysport® / Azzalure®
Dysport (abobotulinumtoxinA) is a prescription injection for temporary improvement in the appearance of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. Dysport is also marketed as Azzalure3 in the EU for the treatment of glabellar lines and lateral canthal lines. Dysport has more than 30 years of clinical experience globally for therapeutic indications and 13 years for aesthetics indications, with extensive clinical evidence of safety and efficacy. It is licensed for aesthetic indications in 85 markets worldwide, Dysport is one of the world’s leading brands of aesthetic neuromodulators with over 100 million treatments delivered in the aesthetics indications to date.

Dysport is a product under license from Ipsen and is manufactured by them. Since 2009, Galderma and Ipsen have had a strategic partnership under which Galderma has promoted and distributed Ipsen’s botulinum toxin type A products in aesthetic indications. The Ipsen-Galderma strategic partnership now covers China, the United States, Europe and the Middle East, Australia, South Korea, Canada, Brazil, Argentina and certain other countries. Ipsen continues to promote Dysport within certain therapeutic indications in countries around the world. For more information on Ipsen, visit www.ipsen.com.

About Restylane®
RESTYLANE is the original non-animal stabilized hyaluronic acid filler with over 25 years of achievement and over 50 million treatments worldwide. NASHA™ and OBT™ technologies make RESTYLANE the world’s most diverse range of fillers to deliver truly individualized results.4,5

The RESTYLANE® portfolio of products includes RESTYLANE®, RESTYLANE® LYFT™, RESTYLANE® KYSSE™, RESTYLANE® VOLYME™, RESTYLANE® DEFYNE™, RESTYLANE® REFYNE™, RESTYLANE® EYELIGHT™ and RESTYLANE® SKINBOOSTERS VITAL™.

About Sculptra®
SCULPTRA works to stimulate the skin’s own collagen production6 and is suitable for increasing the volume of depressed areas, particularly to correct skin depressions such as skin creases, wrinkles, folds, and scars, and for signs of skin aging.7 SCULPTRA is also suitable for large volume corrections of the signs of facial fat loss (lipoatrophy).7

SCULPTRA is an injectable biostimulator containing microparticles of poly-L-lactic acid (PLLA) which gradually revitalizes the skin’s structural foundation, providing natural-looking, long-term results for up to 25 months.8 SCULPTRA was first approved in 1999 in Europe and it is currently available in more than 40 countries globally.

References
1. FACE App Patient Pilot Study, November 2020 – September 2021.170 patients' surveys from 12 countries
2. Alluzience Summary of Product Characteristics, 10 June 2021
3. Azzalure SmPC
4. Data on file (MA-33939)
5. Öhrlund A. Poster presented at AMWC 2019
6. Bohnert K et al. Plast Reconstr Surg 2019;127(4):1684–92
7. Sculptra IFU. 2018
8. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005814/en/


Permalink
https://aetoswire.com/en/news/2601202330044
Contacts
Media
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Rachel Mooney
Global Franchise Communications
rachel.mooney@galderma.com
+41 76 261 64 41

Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85

RevitaLash® Cosmetics Notches Another Big Win in Lawsuit Against Counterfeiters

 (BUSINESS WIRE)--A Federal court has handed another big win to Athena Cosmetics, Inc. (parent company to RevitaLash® Cosmetics) in its battle against counterfeit product sellers AMN Distribution, Inc. and Moishe Newman.

This case brings attention to the defendants’ website called BrushExpress as well as numerous stores on eBay and other online marketplaces they operate under various aliases. In a previous ruling, the Federal court determined that the defendants engaged in trademark infringement involving the use of counterfeiting, and breached a settlement agreement that was signed when Athena first caught them selling counterfeit products.

In this latest ruling, the court ordered the defendants to pay over $1.1 million in damages to Athena Cosmetics. The court found, among other things, that the defendants caused significant harm by selling counterfeit goods and breaching the settlement agreement.

"We are pleased that the Federal court recognized the significant harm caused by these counterfeit products and the defendants’ blatant disregard for both our intellectual property and consumer safety," says Michael Brinkenhoff, M.D., CEO of Athena Cosmetics, Inc. "Athena Cosmetics will continue to take whatever steps necessary to protect our brand and to ensure that consumers can trust that they are buying authentic RevitaLash Cosmetics products that perform as promised."

Identifying counterfeit RevitaLash® Cosmetics products can be difficult, as these imitations are often skillfully crafted to look like the real thing. Checking for key details like missing shrink-wrap, pungent odors, discolored or sticky product formulas, damaged/expired boxes (or no box at all), and missing inventory control numbers can help you determine whether or not a particular product is genuine. Additionally, keep an eye out for misspellings which can often be indicative of a fake item. For your safety and peace of mind, it is best to buy direct from revitalash.com or an authorized reseller. If you have any doubts or suspicions about the authenticity of your purchase, or would like to verify if a reseller is offering authentic product, please contact the RevitaLash® Cosmetics customer care team by calling 877-909-5274 or by emailing customercare@revitalash.com.

About RevitaLash® Cosmetics

RevitaLash® Cosmetics is a worldwide leader in developing advanced lash, brow, and hair beautification products. Established in 2006, the collection includes award-winning RevitaLash® Advanced Eyelash Conditioner and RevitaBrow® Advanced Eyebrow Conditioner, and is available in physician’s offices, spas, salons, online and in specialty retailers across 70+ countries. With their Eternally Pink® mission, RevitaLash® Cosmetics is a supporter of non-profit breast cancer initiatives, donating a portion of proceeds to research and education initiatives, giving back to the breast cancer community year-round, not just in October. For information, visit www.revitalash.com. [RevitaLash® Advanced and RevitaLash® Advanced Sensitive are not available in California]

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005044/en/

Permalink

https://aetoswire.com/en/news/2601202330074

Contacts

Behrman Communications / revitalash@behrmanpr.com